Novel agents for the treatment of Hodgkin lymphoma: brentuximab vedotin and nivolumab

135K views

VJHemOnc – Video Journal of Hematology & HemOnc

2 years ago

Novel agents for the treatment of Hodgkin lymphoma: brentuximab vedotin and nivolumab

Novel agents for the treatment of Hodgkin lymphoma: brentuximab vedotin and nivolumab